How much is BRT Biotechnologies worth in 2026?

BRT Biotechnologies has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has BRT Biotechnologies raised?

BRT Biotechnologies has raised N/A in total funding across 1 funding rounds.

BRT Biotechnologies

Discovery Tools (Healthcare)

BRT Biotechnologies valuation and funding history | Last updated: October 26, 2022 | 1 funding rounds

Current Valuation

N/A

As of October 26, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Oct 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 26, 2022	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

BRT Biotechnologies is currently valued at N/A as of October 26, 2022.

Track BRT Biotechnologies Valuation Updates

Get notified when BRT Biotechnologies raises new funding or valuation changes

Explore More Data

Detailed analysis for BRT Biotechnologies

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock BRT Biotechnologies's valuation history, funding rounds, and growth metrics.

No credit card required

What is BRT Biotechnologies Worth in 2026?

BRT Biotechnologies is a leading private company in the Discovery Tools (Healthcare) sector. Track BRT Biotechnologies's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How BRT Biotechnologies Valuation is Determined

Private company valuations like BRT Biotechnologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.